CORRELATION BETWEEN TSH, T3, T4 AND HISTOLOGICAL TYPES OF THYROID CARCINOMA

Hilda Fitriyani, T. Ibnu Alferraly, Lidya Imelda Laksmi

Abstract


Thyroid carcinoma is a malignancy of the thyroid gland derived from follicular or parafollicular cells. Thyroid carcinoma is the most common endocrine gland malignancy and accounts for approximately 1% of all malignancies. Thyroid carcinoma ranked ninth of 10 most common carcinomas in Indonesia. It may occur at any age but is usually diagnosed between the 3rd and 6th decade. The incidence is three or four times higher in females than in males. Based on histological features thyroid carcinoma is classified into four major types: papillary, follicular, anaplastic and medullary carcinoma. Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3), Thyroxine (T4) are thyroid gland hormones. Low T3 and T4 accompanied with high TSH levels are associated with malignancy in thyroid carcinoma. This study aimed to determine the correlation between TSH, T3, T4 hormone levels, and histological type of thyroid carcinoma at the Adam Malik Hospital Medan between 2013 and 2015. The study was a cross-sectional analytical study. The sample was be obtained using consecutive sampling method. Data were collected from medical records of thyroid carcinoma patients that had undergone pathological examination and thyroid function test at the Adam Malik Hospital Medan between 2013 and 2015. Based on the Chi-Square analysis, there was a significant difference between T3 hormone level with the histopathological type of thyroid carcinoma (p<0.001), however it did not apply to the level of T4 (p = 0.120) and TSH (p = 0.328).


Keywords


Endocrine gland, thyroid carcinoma, TSH, T3, T4

Full Text:

PDF

References


Haugen BR. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer, 2015; 4: 101-103. doi:10.1089/thy.2015.0020.

DeLellis RA, Williams ED. Thyroid and parathyroid tumours: Introduction. In: DeLellis RA, Llyod RV, Heitz PU, Eng C, editors. World Health Organization classification of tumours, pathology and genetics tumours of endocrine organs. Lyon, IARC Press, 2004; 49-77, 86-93.

Maitra A. The endocrine system. In: Kumar V, Abbas AK, Fausto N, Aster J. Pathologic basis of disease. 8th Ed., Philadelphia, Elsevier Saunders, 2010; 1082-1083, 1094-1100.

Syamsuhidayat R, de Jong W. Sistem endokrin. In: Buku ajar ilmu bedah. 2 Ed., Jakarta, Penerbit Buku Kedokteran EGC, 2005; 683-695.

Pacini F, Castagna MG, Brilli L, Pentheroudakis G. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up. Annals of Oncology. 2012; 23 (Supplement 7): vii110-vii119. doi:10.1093/annonc/mds230.

Subekti I. Karsinoma tiroid. In: Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, editors. Buku ajar ilmu penyakit dalam, Jilid 3. 5th Ed., Jakarta, Departeman Ilmu Penyakit Dalam FK UI, 2010; 2031-2037.

British Thyroid Association, Royal College of Physicians. Guidelines for the management of thyroid cancer, 2nd Ed., Report of thyroid cancer guideinesupdate group. London, Royal College of Physicians, 2007; 1. doi:10.1089/thy.2015.0020.

Manuaba TW. Panduan penatalaksanaan kanker solid PERABOI. Jakarta, Sagung Seto, 2010; 53-71.

Katoh H, Yamashita K, Enomoto T, Watanabe M. Classification and general considerations of thyroid cancer. Ann ClinPathol, 2015; 3(1):1045.

Jonklaas J, Nsouli-Maktabi H, Soldin SJ. Endogenous thyrotropin and triidothyronine concentrations in individuals with thyroid cancer. Thyroid. 2008; 18(9): 943-52. doi: 10.1089/thy.2008.0061.

Polyzos SA, Kita M, Efstathiadou Z, Poulakos P, Slavakis A, et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res ClinOncol. 2008; 134: 953-60. doi: 10.1007/s00432-008-0373-7.

Boelaert K. The Association between serum TSH concentration and thyroid cancer. Endocrine-Related Cancer. 2009; 16: 1065-72.

Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J ClinEndocrinolMetab. 2008; 93(3): 809-814. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266959/?report=classic. [Accessed on 14th March 2016].

Ye ZQ, Gu DN, Hu HY, Zhou YL, Hu XQ, Zhang XH. Hashimoto’s thyroiditis, microcalcification, and raised thyrotropin levels within normal range are associated with thyroid cancer. World Journal of Surgical Oncology. 2013; 11: 56. Available at: http://www.wjso.com/content/11/1/56.

Fiore E, Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab. 2012; 97: 1134-45.




DOI: http://dx.doi.org/10.24293/ijcpml.v24i3.1325

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.